Hydroxyapatite Industry Outlook 2020-2025 and Impact of COVID-19 - Featuring Fluidinova, Sofsera, Berkeley Advanced Biomaterials, Taihei Chemical Industrial Co, Sigmagraft, Cam Bioceramics and Others

DUBLIN, July 17, 2020 /PRNewswire/ -- The "Hydroxyapatite Market by Type (Nano-size, Micro-size, Greater than Micrometers) Application (Orthopedic, Dental Care, Plastic Surgery) Orthopedic (Synthetic and Natural Source) Dental Care (Toothpaste and Others) and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global hydroxyapatite market is projected to grow from USD 2.2 billion in the 2020s to USD 3.1 billion by 2025, at a CAGR of 6.8% between 2020 and 2025.

Growing geriatric population, increasing healthcare expenditure, and increasing demand for medical implants are some of the drivers fueling the growth of the Hydroxyapatite market across the globe. However, some of the major restraints for the growth of the Hydroxyapatite market are unfavorable healthcare reforms in the US and unmet performance benchmark by hydroxyapatite such as it has low fracture toughness.

Among types, the nano-size segment of the Hydroxyapatite market is projected to grow at the highest CAGR between 2020 and 2025.

Nano-size Hydroxyapatite is synthetic in nature and is mostly used in orthopedic, dental care products, plastic surgery, food, and pharmaceutical applications. Hydroxyapatite with particle size in nanometers is attracting attention as a bioceramic due to its similarity with human hard tissue. Nano-size Hydroxyapatite is used in the food and dental care products to increase the strength of bones and teeth.

The recent developments of Hydroxyapatite based biomaterials for biomedical application is mainly attributed to the advancement in nanotechnology. This advancement in technology helps overcome the shortcomings of micro-size Hydroxyapatite, such as a large surface area in relation to volume and unusual chemical synergistic effects. Nano-size Hydroxyapatite exhibits improved sinterability and enhanced densification, due to which, the fracture toughness and mechanical properties improve. These properties of nano-size Hydroxyapatite increases its demand in various applications.

Among applications, the dental care segment of the Hydroxyapatite market is projected to grow at a significant rate during the forecast period.

Hydroxyapatite is majorly used in enamel and dental care solutions in the oral care industry. It is one of the main components of teeth that accounts for 97% of enamel and 70% of dentin. In the dental care application, hydroxyapatite is widely preferred over fluoride for remineralization of teeth surfaces. Hydroxyapatite granules are used in various clinical dental practices such as the reconstruction of periodontal bone defects; filling bone defects after cystectomy, after apicoectomy, and after the loss of dental implants; and increasing the thickness of atrophic alveolar ridges.

The Asia-Pacific Hydroxyapatite market is projected to grow at the highest CAGR between 2020 and 2025.

The Asia-Pacific Hydroxyapatite market is projected to grow at the highest CAGR during the forecast period. The growth of the Asia Pacific Hydroxyapatite market can be attributed to the flourishing healthcare sector in the region. The orthopedic application segment led the Asia Pacific Hydroxyapatite market in 2019, followed by the dental care application segment.

Countries such as China, South Korea, Japan, and India are experiencing rapid growth in medical tourism, thereby leading to the growth of their domestic healthcare sectors. This, in turn, is expected to fuel the growth of the Hydroxyapatite market in the region. Moreover, the increasing awareness among masses about the cost-effective treatments and rapidly developing infrastructure of the medical sector in these countries is expected to lead to the growth of the Asia Pacific Hydroxyapatite market during the forecast period.

The key companies operating in the Hydroxyapatite market are FLUIDINOVA (Portugal), SofSera Corporation (Japan), Berkeley Advanced Biomaterials (US), Taihei Chemical Industrial Co. Ltd. (Japan), SigmaGraft (US) and CAM Bioceramics (Netherlands).

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Attractive Growth Opportunity for Hydroxyapatite Market
4.2 Hydroxyapatite Market, by Type
4.3 Hydroxyapatite Market, by Application
4.4 Hydroxyapatite Market in Orthopedic
4.5 Hydroxyapatite Market in Dental Care
4.6 Hydroxyapatite Market, by Region
4.7 APAC Hydroxyapatite Market
4.8 Hydroxyapatite Market, by Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Continuous R&D Activities to Increase Applicability of Hydroxyapatite in Medical Industry
5.2.1.2 Growing Demand for Medical Implants
5.2.1.3 Growing Plastic Surgery and Dental Care Industry in APAC
5.2.2 Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the US
5.2.3 Opportunities
5.2.3.1 Growing Healthcare Industry and Easy Availability of Raw Materials in APAC
5.2.3.2 Growing Hydroxyapatite Based Oral Care Products
5.2.4 Challenges
5.2.4.1 Unmet Performance Benchmark and Increasing Popularity of Bioresorbable Composites
5.3 Porter's Five Forces Analysis
5.4 Hydroxyapatite Patent Analysis
5.5 Yc, Ycc Shift
5.6 Manufacturing Process & Raw Materials
5.7 Impact Factors for Growth
5.8 Impact of COVID-19
5.9 Macroeconomic Indicators

6 Hydroxyapatite Market, by Type
6.1 Introduction
6.2 Nano-Size
6.3 Micro-Size
6.4 Greater Than Micrometers

7 Hydroxyapatite Market, by Application
7.1 Introduction
7.2 Orthopedic
7.2.1 Impact of Megatrends in Orthopedic
7.2.2 Synthetic
7.2.3 Natural Source
7.3 Dental Care
7.3.1 Impact of Megatrends in Dental Care
7.3.2 Toothpaste
7.3.3 Others
7.4 Plastic Surgery
7.4.1 Impact of Megatrends in Plastic Surgery
7.5 Others

8 Hydroxyapatite Market, by Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 Increasingly Aging Population to Significantly Impact the Market (Usd Billion)
8.2.2 Rest of North America
8.3 Europe
8.3.1 Germany
8.3.1.1 High Percentage of Aging Population and Strong Public Healthcare Insurance System Are Key Drivers
8.3.2 France
8.3.2.1 Increasing Awareness About Dental Care and Strong Healthcare Insurance Driving the Market
8.3.3 Italy
8.3.3.1 Recent Recession and High Impact of Covid-19 Will Weaken Growth of Hydroxyapatite
8.3.4 Russia
8.3.4.1 High Ratio of Aging Population to Drive Orthopedic and Dental Care Procedures
8.3.5 UK
8.3.5.1 Growing Medical Tourism in UK is a Major Driver of Hap Market
8.3.6 Portugal
8.3.6.1 Presence of Hydroxyapatite Manufacture in the Country Fueling Demand
8.3.7 Rest of Europe
8.4 APAC
8.4.1 China
8.4.1.1 China Witnessing Increasing Awareness About Oral Healthcare and Growing Beauty Awareness
8.4.2 Japan
8.4.2.1 High Percentage of Aging Population to Fuel the Demand for Hydroxyapatite
8.4.3 South Korea
8.4.3.1 Dental Care and Plastic Surgery Procedures Increasing in the Country
8.4.4 Rest of APAC
8.5 Rest of World
8.5.1 Brazil Will Drive Hydroxyapatite Market in Rest of World

9 Competitive Landscape

10 Customer Landscape

11 Company Profiles
11.1 Fluidinova
11.2 Sofsera Corporation
11.3 Berkeley Advanced Biomaterials
11.4 Taihei Chemical Industrial Co. Ltd.
11.5 Sigmagraft
11.6 Cam Bioceramics
11.7 Granulab (M) Sdn. Bhd.
11.8 Merz North America
11.9 Evonik Industries AG
11.10 Bionnovation
11.11 Other Companies
11.11.1 APS Materials
11.11.2 Sangi Co. Ltd.
11.11.3 ALB Technology
11.11.4 Medicoat AG
11.11.5 Promimic

For more information about this report visit https://www.researchandmarkets.com/r/wzmvud

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/hydroxyapatite-industry-outlook-2020-2025-and-impact-of-covid-19---featuring-fluidinova-sofsera-berkeley-advanced-biomaterials-taihei-chemical-industrial-co-sigmagraft-cam-bioceramics-and-others-301095460.html

SOURCE Research and Markets